In the closing of the recent trading day, Pfizer (PFE) stood at $26.97, denoting a -1.61% move from the preceding trading day.
Pfizer Inc. (NYSE: PFE) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC ("Tutanota") to purchase up to ...
Pfizer Inc. (NYSE: PFE) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC ...
Drug stocks can be somewhat volatile. Things like clinical setbacks or patent cliffs can sink their stock prices or erode ...
As the pandemic tailwind fades, both Pfizer (PFE) and Moderna (MRNA) have posted financial results that have disappointed investors. Yet, facing the same headwinds, these two companies ...
Pfizer (PFE 1.60%) and Moderna (MRNA 1.89%) were both leaders in the coronavirus vaccine market. However, as sales of these ...
Serina Therapeutics (SER) stock jumped 39% after-hours on news of a $30M private placement and Greg Bailey's appointment as ...
First tranche of $15 million expected to close on March 20, 2026; second tranche of up to $15 million available, for up to $30 million in total ...
Pfizer Inc. Q4 shows post-COVID growth, Seagen-fueled oncology gains, and obesity upside. Click for this updated look at PFE at its earnings and acquisition.
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional ...
Pfizer Inc. (NYSE:PFE) is one of Jim Cramer’s latest stock calls as he discussed the bullish AI investment thesis amid the ...
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results